Ansari R - Search Results

1

Paclitaxel plus bevacizumab in patients with chemosensitive relapsed small cell lung cancer: a safety, feasibility, and efficacy study from the Hoosier Oncology Group.

Jalal S, Bedano P, Einhorn L, Bhatia S, Ansari R, Bechar N, Koneru K, Govindan R, Wu J, Yu M, Schneider B, Hanna N. Jalal S, et al. Among authors: ansari r. J Thorac Oncol. 2010 Dec;5(12):2008-11. doi: 10.1097/JTO.0b013e3181f77b6e. J Thorac Oncol. 2010. PMID: 21102263 Free article.

2

Etoposide, ifosfamide and cisplatin (VIP) plus concurrent radiation therapy for previously untreated limited small cell lung cancer (SCLC): a Hoosier Oncology Group (HOG) phase II study.

Hanna N, Ansari R, Fisher W, Shen J, Jung SH, Sandler A. Hanna N, et al. Among authors: ansari r. Lung Cancer. 2002 Mar;35(3):293-7. doi: 10.1016/s0169-5002(01)00429-9. Lung Cancer. 2002. PMID: 11844604 Clinical Trial.

3

A phase II study of weekly gemcitabine and paclitaxel in patients with previously untreated stage IIIb and IV non-small cell lung cancer.

Bhatia S, Hanna N, Ansari R, Pletcher W, Einhorn L, Ng E, Sandler A. Bhatia S, et al. Among authors: ansari r. Lung Cancer. 2002 Oct;38(1):73-7. doi: 10.1016/s0169-5002(02)00145-9. Lung Cancer. 2002. PMID: 12367796 Clinical Trial.

4

Carboplatin plus paclitaxel and sequential radiation followed by consolidation carboplatin and paclitaxel in patients with previously untreated locally advanced NSCLC. A Hoosier Oncology Group (HOG) phase II study.

Bhatia S, Hanna N, Ansari R, Einhorn L, Sandler A. Bhatia S, et al. Among authors: ansari r. Lung Cancer. 2002 Oct;38(1):85-9. doi: 10.1016/s0169-5002(02)00146-0. Lung Cancer. 2002. PMID: 12367798 Clinical Trial.

5

Randomized phase III trial comparing irinotecan/cisplatin with etoposide/cisplatin in patients with previously untreated extensive-stage disease small-cell lung cancer.

Hanna N, Bunn PA Jr, Langer C, Einhorn L, Guthrie T Jr, Beck T, Ansari R, Ellis P, Byrne M, Morrison M, Hariharan S, Wang B, Sandler A. Hanna N, et al. Among authors: ansari r. J Clin Oncol. 2006 May 1;24(13):2038-43. doi: 10.1200/JCO.2005.04.8595. J Clin Oncol. 2006. PMID: 16648503 Clinical Trial.

6

Phase II trial of cetuximab in patients with previously treated non-small-cell lung cancer.

Hanna N, Lilenbaum R, Ansari R, Lynch T, Govindan R, Jänne PA, Bonomi P. Hanna N, et al. Among authors: ansari r. J Clin Oncol. 2006 Nov 20;24(33):5253-8. doi: 10.1200/JCO.2006.08.2263. J Clin Oncol. 2006. PMID: 17114658 Clinical Trial.

7

Phase III study of cisplatin, etoposide, and concurrent chest radiation with or without consolidation docetaxel in patients with inoperable stage III non-small-cell lung cancer: the Hoosier Oncology Group and U.S. Oncology.

Hanna N, Neubauer M, Yiannoutsos C, McGarry R, Arseneau J, Ansari R, Reynolds C, Govindan R, Melnyk A, Fisher W, Richards D, Bruetman D, Anderson T, Chowhan N, Nattam S, Mantravadi P, Johnson C, Breen T, White A, Einhorn L; Hoosier Oncology Group; US Oncology. Hanna N, et al. Among authors: ansari r. J Clin Oncol. 2008 Dec 10;26(35):5755-60. doi: 10.1200/JCO.2008.17.7840. Epub 2008 Nov 10. J Clin Oncol. 2008. PMID: 19001323 Clinical Trial.

8

Pemetrexed in second line and beyond small cell lung cancer: a Hoosier Oncology Group phase II study.

Jalal S, Ansari R, Govindan R, Bhatia S, Bruetman D, Fisher W, Masters G, White A, Stover D, Yu M, Hanna N; Hoosier Oncology Group. Jalal S, et al. Among authors: ansari r. J Thorac Oncol. 2009 Jan;4(1):93-6. doi: 10.1097/JTO.0b013e31818de1e6. J Thorac Oncol. 2009. PMID: 19096313 Free article. Clinical Trial.

9

Pemetrexed plus cetuximab in patients with recurrent non-small cell lung cancer (NSCLC): a phase I/II study from the Hoosier Oncology Group.

Jalal S, Waterhouse D, Edelman MJ, Nattam S, Ansari R, Koneru K, Clark R, Richards A, Wu J, Yu M, Bottema B, White A, Hanna N. Jalal S, et al. Among authors: ansari r. J Thorac Oncol. 2009 Nov;4(11):1420-4. doi: 10.1097/JTO.0b013e3181b624ae. J Thorac Oncol. 2009. PMID: 19701110 Free article. Clinical Trial.

10

Sunitinib plus paclitaxel in patients with advanced esophageal cancer: a phase II study from the Hoosier Oncology Group.

Schmitt JM, Sommers SR, Fisher W, Ansari R, Robin E, Koneru K, McClean J, Liu Z, Tong Y, Hanna N. Schmitt JM, et al. Among authors: ansari r. J Thorac Oncol. 2012 Apr;7(4):760-3. doi: 10.1097/JTO.0b013e31824abc7c. J Thorac Oncol. 2012. PMID: 22425927 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

462 results

Search Page

Filters